Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Epigenetic treatment of myelodysplastic syndromes and acute myeloid leukemias Leone G; D'Alo F; Zardo G; Voso MT; Nervi CCurr Med Chem 2008[]; 15 (13): 1274-87Epigenetic mechanisms affecting chromatin structure contribute to regulate gene expression and assure the inheritance of information, which are essential for the proper expression of key regulatory genes in healthy cells, tissues and organs. In the medical field, an increasing body of evidence indicates that altered gene expression or de-regulated gene function lead to disease. Cancer cells also suffer a profound change in the genomic methylation patterns and chromatin status. Aberrant DNA methylation patterns, changes in chromatin structure and in gene expression are common in all kind of tumor types. However, studies on leukemias have provided paradigmatic examples for the functional implications of the epigenetic alterations in cancer development and progression as well as their relevance for therapeutical targeting.|DNA Methylation/drug effects[MESH]|Enzyme Inhibitors/metabolism/pharmacology/therapeutic use[MESH]|Epigenesis, Genetic/*drug effects[MESH]|Histone Deacetylase Inhibitors[MESH]|Histone Deacetylases/metabolism[MESH]|Humans[MESH]|Leukemia, Myeloid, Acute/*drug therapy/enzymology/*genetics/metabolism[MESH]|Myelodysplastic Syndromes/*drug therapy/enzymology/*genetics/metabolism[MESH] |
